These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39005364)

  • 21. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
    Ayaz S; Dibben O; Chapman D
    Vaccine; 2021 Nov; 39(46):6735-6745. PubMed ID: 34663504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyamine Depletion Inhibits Bunyavirus Infection via Generation of Noninfectious Interfering Virions.
    Mastrodomenico V; Esin JJ; Graham ML; Tate PM; Hawkins GM; Sandler ZJ; Rademacher DJ; Kicmal TM; Dial CN; Mounce BC
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective lethal mutagenesis of influenza virus by three nucleoside analogs.
    Pauly MD; Lauring AS
    J Virol; 2015 Apr; 89(7):3584-97. PubMed ID: 25589650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.
    Kupke SY; Riedel D; Frensing T; Zmora P; Reichl U
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatic analysis of defective viral genomes in SARS-CoV-2 and its impact on population infection characteristics.
    Xu Z; Peng Q; Song J; Zhang H; Wei D; Demongeot J; Zeng Q
    Front Immunol; 2024; 15():1341906. PubMed ID: 38348041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza Virus Reassortment Is Enhanced by Semi-infectious Particles but Can Be Suppressed by Defective Interfering Particles.
    Fonville JM; Marshall N; Tao H; Steel J; Lowen AC
    PLoS Pathog; 2015 Oct; 11(10):e1005204. PubMed ID: 26440404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study.
    Bragstad K; Nielsen LP; Fomsgaard A
    Virol J; 2008 Mar; 5():40. PubMed ID: 18325125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-like Particles: Measures and Biological Functions.
    Bhat T; Cao A; Yin J
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
    Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U
    Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective Influenza A Virus RNA Products Mediate MAVS-Dependent Upregulation of Human Leukocyte Antigen Class I Proteins.
    Rahim MMA; Parsons BD; Price EL; Slaine PD; Chilvers BL; Seaton GS; Wight A; Medina-Luna D; Dey S; Grandy SL; Anderson LE; Zamorano Cuervo N; Grandvaux N; Gaglia MM; Kelvin AA; Khaperskyy DA; McCormick C; Makrigiannis AP
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.
    Trebbien R; Christiansen CB; Fischer TK
    J Clin Virol; 2018 May; 102():1-6. PubMed ID: 29448067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
    Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential.
    Spieler EE; Moritz E; Stertz S; Hale BG
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32848003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
    Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
    Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection.
    Zhou T; Gilliam NJ; Li S; Spandau S; Osborn RM; Connor S; Anderson CS; Mariani TJ; Thakar J; Dewhurst S; Mathews DH; Huang L; Sun Y
    mBio; 2023 Jun; 14(3):e0025023. PubMed ID: 37074178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting influenza A virus by splicing inhibitor herboxidiene reveals the importance of subtype-specific signatures around splice sites.
    Han YJ; Lee KM; Wu GH; Gong YN; Dutta A; Shih SR
    J Biomed Sci; 2023 Feb; 30(1):10. PubMed ID: 36737756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function.
    Patil A; Anhlan D; Ferrando V; Mecate-Zambrano A; Mellmann A; Wixler V; Boergeling Y; Ludwig S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.
    Phipps KL; Marshall N; Tao H; Danzy S; Onuoha N; Steel J; Lowen AC
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective Viral Particles Produced in Mast Cells Can Effectively Fight Against Lethal Influenza A Virus.
    Huo C; Cheng J; Xiao J; Chen M; Zou S; Tian H; Wang M; Sun L; Hao Z; Hu Y
    Front Microbiol; 2020; 11():553274. PubMed ID: 33250863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.